Ingestion of Beta-alanine Effects in Well-trained Tennis Players

Placebo Clinical Trial

— BETA_TENNIS  

Official title:

Ingestion of Beta-alanine Improves Neuromuscular Performance in Well-trained Tennis. A Randomized Controlled Trial.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05427409
• Other study ID #: UFran_Vitoria
• Status: Completed
• Phase: N/A
• Start date: November 4, 2020
• Est. completion date: June 1, 2021

Study information

• Verified date: June 2022
• Source: Universidad Francisco de Vitoria
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Beta-alanine is considered as ergogenic aids with good to strong evidence for improving sports performance in specific sports context scenarios. However, most of the studies has been realized in endurance, with limited evidence in intermittent sports, especially in racket sports. Thus, the aim of this study was to explore the effects of 4-weeks ingestion of beta-alanine on neuromuscular performance in well-trained tennis players.

Description:

Fourteen tennis players (23.3 ±3.7 years) between 50-250 national tennis ranking participated in this study. Participants were randomly divided into two groups that realized a neuromuscular battery after beta-alanine (4.8 gr/daily during 4-weeks) or placebo (i.e., fructose) (4.8 grams/daily during 4-weeks). Before and after the supplementation period tennis performed a neuromuscular test battery in a tennis court consisted in different test such as; serve velocity, countermovement jump, isometric handgrip strength, 10-m sprint, modified 5-0-5 agility test and repeated sprint ability. After 48 h of the realization of neuromuscular test battery, tennis players performed VO2max consumption test (i.e., treadmill).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: June 1, 2021
• Est. primary completion date: June 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• Well-trained tennis players, between 18-35 years old (50-200 between tennis ranking)

Exclusion Criteria:

• Suffering from any chronic pathology or an injury in the month prior to the investigation.
• Intolerance to beta-alanine ingestion
• Amateur tennis players.

Related Conditions & MeSH terms

• Placebo

Intervention

Dietary Supplement:
• Beta-alanine supplementation
In a randomized order, two groups (n=7) was randomly assigned to beta-alanine and placebo during a 4-weeks period

Locations

Country	Name	City	State
Spain	Universidad Francisco de Vitoria	Pozuelo De Alarcón	Madrid

Sponsors (3)

Lead Sponsor	Collaborator
Universidad Francisco de Vitoria	University of Greenwich, University of Seville

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Repeated sprint ability test.	Infrared photocells system (Microgate, Italy)	4-weeks
Primary	VO2 max treadmill test	Using VO2 max analyzer (Ergostik, Geratherm Respiratory, Ergostik, Geratherm, Germany)	4-weeks
Secondary	Serve velocity	Stroke velocity radar gun (Radar Pocket, South Korea)	4-weeks
Secondary	Contermovement Jump	Contact Jump (Chronojump, Spain)	4-weeks
Secondary	10m sprint	Infrared photocells system (Microgate, Italy)	4-weeks
Secondary	Isometric handgrip strength	Hand held dynamometer (Takei, Japan)	4-weeks
Secondary	Modified agility test 5-0-5	Infrared photocells system (Microgate, Italy)	4-weeks